Erectile Function and Semaglutide A claims-based analysis found a higher likelihood of erectile dysfunction (ED) diagnoses and testosterone deficiency among non-diabetic men prescribed semaglutide compared with controls, though the overall incidence was still low
The semaglutide cohort ( n = 668) compared with the non-GLP-1RA anti-obesity medications cohort ( n = 21,445) had a higher prevalence of adverse socioeconomic determinants of health, problems related to lifestyle, severe obesity, obesity-associated comorbidities and mental disorders
Andrew Huberman: It's rough
However, it is crucial to understand that no GLP-1 patches are currently licensed by the MHRA in the UK
They do not mandate lifelong treatment for every patient or provide an elective taper protocol
Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human TSLP